Dr.Roya Mohammadi Mey Abad | Psoriasis treatment innovations| Editorial Board Member
Dr.Roya Mohammadi Mey Abad | Psoriasis treatment innovations| Editorial Board Member
Ph. D | University of Barcelona | Spain
Dr. Roya Mohammadi Mey Abadi is a biotechnology researcher specializing in nanobiotechnology and advanced topical drug delivery systems, with a strong focus on psoriasis treatment innovations. Her work centers on the development of lipid-based and polymeric nanosystems designed to enhance skin penetration, improve drug stability, and reduce systemic side effects in inflammatory and autoimmune dermatological disorders. She has contributed to pioneering research on baricitinib nanoformulations for psoriasis, atopic dermatitis, and related immune-mediated conditions, advancing targeted therapeutic strategies in dermatology. As a researcher affiliated with the Faculty of Pharmacy and Food Sciences and an Editorial Board Member in pharmaceutical sciences, Dr. Mey Abadi actively supports high-impact translational research. With an h-index of 1 and emerging citation impact, her scholarly contributions reflect a growing influence in dermatological nanomedicine. Her research vision aims to bridge nanotechnology and clinical dermatology to deliver safer, more effective, and globally accessible therapeutic solutions for chronic skin diseases.
100
10
5
0
64
5
2
🟥 Documents
🟩 h-index
View Google Scholar
View ORCID profile
Featured Publications
Assessing the solubility of baricitinib and drug uptake in different tissues using absorption and fluorescence spectroscopies
Baricitinib Liposomes as a New Approach for the Treatment of Sjögren’s Syndrome
Formulation of polymeric nanoparticles loading baricitinib as a topical approach in ocular application
Baricitinib lipid-based nanosystems as a topical alternative for atopic dermatitis treatment
–. Baricitinib lipid-based nanosystems as a topical alternative for atopic dermatitis treatment
Lipid-based formulation of baricitinib for the topical treatment of psoriasis